Catheter Precision shareholders approve reverse stock split, authorize share decrease

Catheter Precision, Inc.

James Caruso and Andrew Arno elected as Class III directors with ~2.6M votes each.
Amendment to reduce authorized common stock approved by ~4.07M votes.
Reverse stock split (1:5 to 1:15) authorized by ~3.99M votes.
2M additional shares for 2023 Equity Incentive Plan approved by ~2.36M votes.
Nonbinding vote on executive compensation set to every three years based on shareholder preference.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.